Drug project high-priority medications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 164: | Line 164: | ||
| 2018||3||Symdeko||Tezacaftor; ivacaftor||[[Tezacaftor; ivacaftor]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Symdeko Symdeko]||2/12/2018 | | 2018||3||Symdeko||Tezacaftor; ivacaftor||[[Tezacaftor; ivacaftor]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Symdeko Symdeko]||2/12/2018 | ||
|- | |- | ||
| 2018||2||Biktarvy||Bictegravir, embitcitabine, tenofovir alafenamide||[[Bictegravir, embitcitabine, tenofovir alafenamide]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Biktarvy Biktarvy]||2/7/2018 | | 2018||2||Biktarvy||Bictegravir sodium, embitcitabine, tenofovir alafenamide||[[Bictegravir sodium, embitcitabine, tenofovir alafenamide]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Biktarvy Biktarvy]||2/7/2018 | ||
|- | |- | ||
| 2018||1||Lutathera||Lutetium lu 177 dotatate||[[Lutetium lu 177 dotatate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lutathera Lutathera]||1/26/2018 | | 2018||1||Lutathera||Lutetium lu 177 dotatate||[[Lutetium lu 177 dotatate]]||[https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Lutathera Lutathera]||1/26/2018 | ||
|} | |} | ||
</div> | </div> |
Revision as of 19:09, 27 June 2019
WikiDoc Drug Project — High-Priority Medications
- Template here: Drug page template
- Example here: Clopidogrel
- FDA package insert here: DailyMed
List of high-priority medications
Year | No. | Brand Name | Active Ingredient | Page Link | DailyMed Search | Approval Date |
2019 | 12 | Polivy | Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq | Polivy | 6/10/2019 |
2019 | 11 | Piqray | Alpelisib | Alpelisib | Piqray | 5/24/2019 |
2019 | 10 | Vyndaqel | Tafamidis meglumine | Tafamidis meglumine | Vyndaqel | 5/3/2019 |
2019 | 9 | Skyrizi | Risankizumab | Risankizumab | Skyrizi | 4/23/2019 |
2019 | 8 | Balversa | Erdafitinib | Erdafitinib | Balversa | 4/12/2019 |
2019 | 7 | Evenity | Romosozumab | Romosozumab | Evenity | 4/9/2019 |
2019 | 6 | Mayzent | Siponimod | Siponimod | Mayzent | 3/26/2019 |
2019 | 5 | Sunosi | Solriamfetol | Solriamfetol | Sunosi | 3/20/2019 |
2019 | 4 | Zulresso | Brexanolone | Brexanolone | Zulresso | 3/19/2019 |
2019 | 3 | Egaten | Triclabendazole | Triclabendazole | Egaten | 2/13/2019 |
2019 | 2 | Cablivi | Caplacizumab | Caplacizumab | Cablivi | 2/6/2019 |
2019 | 1 | Jeuveau | prabotulinum toxin type a powder | prabotulinum toxin type a powder | Jeuveau | 2/1/2019 |
2018 | 59 | Ultomiris | Ravulizumab | Ravulizumab | Ultomiris | 12/21/2018 |
2018 | 58 | Elzonris | Tagraxofusp-erzs | Tagraxofusp-erzs | Elzonris | 12/21/2018 |
2018 | 57 | Asparlas | Calaspargase pegol-mknl | Calaspargase pegol-mknl | Asparlas | 12/20/2018 |
2018 | 56 | Motegrity | Prucalopride | Prucalopride | Motegrity | 12/14/2018 |
2018 | 55 | Xospata | Gilteritinib | Gilteritinib | Xospata | 11/28/2018 |
2018 | 54 | Firdapse | Amifampridine | Amifampridine | Firdapse | 11/28/2028 |
2018 | 53 | Vitrakvi | Larotrectinib | Larotrectinib | Vitrakvi | 11/26/2018 |
2018 | 52 | Daurismo | Glasdegib | Glasdegib | Daurismo | 11/21/2018 |
2018 | 51 | Gamifant | Emapalumab-lzsgemapalumab-lzsg | Emapalumab-lzsgemapalumab-lzsg | Gamifant | 11/20/2018 |
2018 | 50 | Aemcolo | Rifamycin | Rifamycin | Aemcolo | 11/16/2018 |
2018 | 49 | Yupelri | Revefenacin | Revefenacin | Yupelri | 11/9/2018 |
2018 | 48 | Lorbrena | Lorlatinib | Lorlatinib | Lorbrena | 11/2/2018 |
2018 | 47 | Xofluza | Baloxavir marboxil | Baloxavir marboxil | Xofluza | 10/24/2018 |
2018 | 46 | Talzenna | Talazoparib | Talazoparib | Talzenna | 10/16/2018 |
2018 | 45 | Tegsedi | Inotersen | Inotersen | Tegsedi | 10/5/2018 |
2018 | 44 | Revcovi | Elapegademase-lvlr | Elapegademase-lvlr | Revcovi | 10/5/2018 |
2018 | 43 | Nuzyra | Omadacycline | Omadacycline | Nuzyra | 10/2/2018 |
2018 | 42 | Seysara | Sarecycline | Sarecycline | Seysara | 10/1/2018 |
2018 | 41 | Libtayo | Cemiplimab-rwlc | Cemiplimab-rwlc | Libtayo | 9/28/2018 |
2018 | 40 | Vizimpro | Dacomitinib | Dacomitinib | Vizimpro | 9/27/2018 |
2018 | 39 | Emgality | Galcanezumab-gnlm | Galcanezumab-gnlm | Emgality | 9/27/2018 |
2018 | 38 | Copiktra | Duvelisib | Duvelisib | Copiktra | 9/24/2018 |
2018 | 37 | Ajovy | Fremanezumab-vfrm | Fremanezumab-vfrm | Ajovy | 9/14/2018 |
2018 | 36 | Lumoxiti | Moxetumomab pasudotox-tdfk | Moxetumomab pasudotox-tdfk | Lumoxiti | 9/13/2018 |
2018 | 35 | Pifeltro | Doravirine | Doravirine | Pifeltro | 8/30/2018 |
2018 | 34 | Xerava | Eravacycline | Eravacycline | Xerava | 8/27/2018 |
2018 | 33 | Takhzyro | Lanadelumab | Lanadelumab | Takhzyro | 8/23/2018 |
2018 | 32 | Oxervate | Cenegermin-bkbj | Cenegermin-bkbj | Oxervate | 8/22/2018 |
2018 | 31 | Diacomit | Stiripentol | Stiripentol | Diacomit | 8/20/2018 |
2018 | 30 | Galafold | Migalastat | Migalastat | Galafold | 8/10/2018 |
2018 | 29 | Annovera | Segesterone acetate and ethinyl estradiol vaginal system | Segesterone acetate and ethinyl estradiol vaginal system | Annovera | 8/10/2018 |
2018 | 28 | Onpattro | Patisiran | Patisiran | Onpattro | 8/10/2018 |
2018 | 27 | Poteligeo | Mogamulizumab-kpkc | Mogamulizumab-kpkc | Poteligeo | 8/8/2018 |
2018 | 26 | Mulpleta | Lusutrombopag | Lusutrombopag | Mulpleta | 7/31/2018 |
2018 | 25 | Omegaven | Fish oil triglycerides | Fish oil triglycerides | Omegaven | 7/27/2018 |
2018 | 24 | Orilissa | Elagolix sodium | Elagolix sodium | Orilissa | 7/23/2018 |
2018 | 23 | Krintafel | Tafenoquine | Tafenoquine | Krintafel | 7/20/2018 |
2018 | 22 | Tibsovo | Ivosidenib | Ivosidenib | Tibsovo | 7/20/2018 |
2018 | 21 | TPOXX | Tecovirimat | Tecovirimat | TPOXX | 7/13/2018 |
2018 | 20 | Braftovi | Encorafenib | Encorafenib | Braftovi | 6/27/2018 |
2018 | 19 | Mektovi | Binimetinib | Binimetinib | Mektovi | 6/27/2018 |
2018 | 18 | Zemdri | Plazomicin | Plazomicin | Zemdri | 6/25/2018 |
2018 | 17 | Epidioloex | Cannabidiol | Cannabidiol | Epidioloex | 6/25/2018 |
2018 | 16 | Moxidectin | Moxidectin | Moxidectin | Moxidectin | 6/13/2018 |
2018 | 15 | Olumiant | Baricitinib | Baricitinib | Olumiant | 5/31/2018 |
2018 | 14 | Palynziq | Pegvaliase-pqpz | Pegvaliase-pqpz | Palynziq | 5/24/2018 |
2018 | 13 | Doptelet | Avatrombopag | Avatrombopag | Doptelet | 5/21/2018 |
2018 | 12 | Lokelma | Sodium zirconium cyclosilicate | Sodium zirconium cyclosilicate | Lokelma | 5/18/2018 |
2018 | 11 | Aimovig | Erenumab-aooe | Erenumab-aooe | Aimovig | 5/17/2018 |
2018 | 10 | Lucemyra | Lofexidine hydrochloride | Lofexidine hydrochloride | Lucemyra | 5/16/2018 |
2018 | 9 | Akynzeo | Fosnetupitant and palonosetron | Fosnetupitant and palonosetron | Akynzeo | 4/19/2018 |
2018 | 8 | Crysvita | Burosumab-twza | Burosumab-twza | Crysvita | 4/17/2018 |
2018 | 7 | Tavalisse | Fostamatinib | Fostamatinib | Tavalisse | 4/17/2018 |
2018 | 6 | Ilumya | Tildrakizumab | Tildrakizumab | Ilumya | 3/20/2018 |
2018 | 5 | Trogarzo | Ibalizumab-uiyk | Ibalizumab-uiyk | Trogarzo | 3/6/2018 |
2018 | 4 | Erleada | Apalutamide | Apalutamide | Erleada | 2/14/2018 |
2018 | 3 | Symdeko | Tezacaftor; ivacaftor | Tezacaftor; ivacaftor | Symdeko | 2/12/2018 |
2018 | 2 | Biktarvy | Bictegravir sodium, embitcitabine, tenofovir alafenamide | Bictegravir sodium, embitcitabine, tenofovir alafenamide | Biktarvy | 2/7/2018 |
2018 | 1 | Lutathera | Lutetium lu 177 dotatate | Lutetium lu 177 dotatate | Lutathera | 1/26/2018 |